0001685071-16-000001.txt : 20160923 0001685071-16-000001.hdr.sgml : 20160923 20160923150052 ACCESSION NUMBER: 0001685071-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160923 DATE AS OF CHANGE: 20160923 EFFECTIVENESS DATE: 20160923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dova Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001685071 IRS NUMBER: 813858961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-271207 FILM NUMBER: 161899636 BUSINESS ADDRESS: STREET 1: 200 GARRETT STREET STREET 2: SUITE S CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: 434-980-8105 MAIL ADDRESS: STREET 1: 200 GARRETT STREET STREET 2: SUITE S CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 D 1 primary_doc.xml X0707 D LIVE 0001685071 Dova Pharmaceuticals, Inc. 200 GARRETT STREET SUITE S CHARLOTTESVILLE VA VIRGINIA 22902 434-980-8105 DELAWARE Dova Pharmaceuticals, LLC PBM AKX Holdings, LLC None Corporation true 2016 Paul B. Manning 200 Garrett Street Suite S Charlottesville VA VIRGINIA 22902 Executive Officer Director Promoter John A. Stalfort 200 Garrett Street Suite S Charlottesville VA VIRGINIA 22902 Executive Officer Director Promoter James C. Reebals 200 Garrett Street Suite S Charlottesville VA VIRGINIA 22902 Executive Officer Promoter Eugene R. Scavola 200 Garrett Street Suite S Charlottesville VA VIRGINIA 22902 Executive Officer Promoter Damian deGoa 200 Garrett Street Suite S Charlottesville VA VIRGINIA 22902 Executive Officer Promoter Russell T. Schundler 200 Garrett Street Suite S Charlottesville VA VIRGINIA 22902 Executive Officer Promoter Hossein Ekrami 51 Astor Place 10th Floor New York NY NEW YORK 10003 Director PBM Capital Investments LLC 200 Garrett Street Suite S Charlottesville VA VIRGINIA 22902 Promoter BKB Growth Investments, LLC 200 Garrett Street Suite O Charlottesville VA VIRGINIA 22902 Promoter Pharmaceuticals Decline to Disclose 06b false 2016-09-19 false true false 2500000 40000000 10000000 30000000 The Issuer's Board may have one or more closings at any time and from time to time after receiving investments totaling $10,000,000. The Issuer's Board may also accept less than the stated minimum investment amount of $2,500,000 in its discretion. false 1 0 true 0 true The Issuer may in the future retain a broker in connection with the offering but has not yet done so. 600000 true false Dova Pharmaceuticals, Inc. /Russell T. Schundler/ Russell T. Schundler Secretary 2016-09-23